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ABSTRACT 
DECREASING COST IN THE GI ENDOSCOPY SUITE BY  
UTILIZING BEST SEDATION PRACTICES 
by Casey Brianne Mancini 
May 2017 
Colorectal cancer is a leading cause of cancer death in the United States (Mandel 
et al., 2008; Siegel, DeSantis, & Jemal, 2014).  Because this lethal disease claims lives of 
many people every year, more patients are undergoing screening colonoscopies, which 
have greatly aided in decreasing the number of colorectal cancer deaths (Siegel et al., 
2014).  The most common form of sedation for colonoscopies is moderate sedation with a 
benzodiazepine and an opioid (Cohen, Hightower, Wood, Miller, & Aisenberg, 2004; 
Lera dos Santos et al., 2013).  However, sedation by anesthesia providers using propofol 
is becoming more common and may aid in reducing recovery and discharge times from 
the postoperative anesthesia care unit (PACU) as well as reducing overall costs. A 
retrospective chart review (N=176; 88 in propofol group and 88 in benzodiazepine and 
opioid group) was performed to determine if propofol sedation did reduce discharge 
times and decrease overall costs for the patient.  Patients included in this study underwent 
colonoscopy, were ASA PS I or II, and between the ages of 18 and 55.  Exclusion criteria 
for this project were as follows: ASA PS III or IV, non-English speaking, pregnancy, 
allergy to eggs, fentanyl, or midazolam, previous neurological deficit, patients scheduled 
for colonoscopy and EGD in the same day, hospital inpatients undergoing colonoscopy, 
and patients undergoing emergency procedures.  A one tailed independent groups t-test 
was performed on the mean time from procedure end until discharge time in minutes.  
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The hypothesis that colonoscopy patients sedated with propofol would be discharged 
faster than patients receiving a benzodiazepine and an opioid for sedation was accepted 
(group propofol M= 80.99, SD= 15.36 and group benzodiazepine and opioid M= 84.58, 
SD= 13.42, p= 0.05).  A cost analysis revealed that sedation with propofol by anesthesia 
providers was more costly.  While propofol patients are discharged faster, moderate 
sedation with a benzodiazepine and an opioid may be more cost efficient if the same 
number of patients underwent the procedure, however the decreased time may permit 
more revenue via greater number of cases performed.  Interviews with providers after 
presenting the findings revealed future stakeholder strategies for a practice change. 
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CHAPTER I - INTRODUCTION 
In the healthcare industry, today cost efficiency is extremely important.  
Organizations detest wasting time, supplies, and other tangible and intangible resources.  
Since colonoscopies are one of the most common procedures performed today, utilizing 
the best sedation practice under which to perform colonoscopies is one-way healthcare 
providers can increase both financial and time savings for the organization and the 
patient. 
Background and Significance 
One of the most prevalent health issues today is colorectal cancer.  Colorectal 
cancer outcomes have improved from being the leading cause of cancer mortality in the 
late 1940’s and early 1950’s and the second leading cause of cancer mortality less than 
10 years ago to being the third leading cause of cancer mortality today (Mandel et al., 
2008; Siegel et al., 2014).  Many factors such as diet, lifestyle changes, early detection, 
and treatment options have contributed to the decreased incidence of this fatal disease 
(Siegel et al., 2014).  Because of the importance of early detection in colorectal cancer, 
colonoscopies have effectively reduced the number of deaths (Mandel et al., 2008).  In 
2000, 19% of patients, ages 50 to 75 years, had a routine screening colonoscopy.  This 
percentage dramatically increased to 55% in 2010 among the same age range (Siegel et 
al., 2014).  Although considered a routine procedure, colonoscopies are not without 
discomfort for the patient (Mandel et al., 2008).   
To improve patient comfort and tolerance, colonoscopies and other endoscopic 
procedures in the gastrointestinal (GI) suite are typically performed while the patient is 
sedated.  In a 2006 survey, more than 98% of colonoscopies in the United States were 
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performed under sedation (Lera dos Santos et al., 2013).  Sedation practices range from 
mild sedation to moderate (conscious) sedation to deep sedation to general anesthesia 
(Lera dos Santos et al., 2013; McQuaid & Lane, 2008).  Sedation serves several purposes 
during endoscopic procedures, including keeping the patient comfortable, improving 
efficiency of the procedure, and obtaining better quality results (Lera dos Santos et al., 
2013).   
The most commonly utilized sedation regimen is the combination of a 
benzodiazepine and an opioid for production of anxiolysis and analgesia (Cohen et al., 
2004; Lera dos Santos, et. al., 2013).  This combination of drugs is used in over 75% of 
endoscopic facilities in the United States (Lera dos Santos et al., 2013).  The short half-
life, ability to produce anterograde amnesia, and anxiolytic and sedative properties of 
midazolam make it the most desirable benzodiazepine for use (Lera dos Santos et al., 
2013).  Among the opioid drugs utilized for sedation purposes, fentanyl is the most 
frequently used drug of the opioid class, but meperidine is also useful for sedation (Lera 
dos Santos et al., 2013).  Benzodiazepines and opioids can be administered by either a 
Registered Nurse (RN) or an anesthesia provider. 
A hypnotic agent, propofol, used for the induction of anesthesia, is also used for 
sedation (Lera dos Santos et al., 2013).  The onset of action of propofol is almost 
immediate, and the half-life is short, making it ideal for rapid recovery (Lera dos Santos 
et al., 2013).  In addition to desirable properties for sedation, such as quicker recovery 
than other regimens, both patient and physician satisfaction is high with propofol (Lera 
dos Santos et al., 2013; Sipe et al., 2002).  However, propofol, in many states, is limited 
to administration by anesthesia providers. 
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PICO/ Project Question 
 For patients in the GI endoscopy suite undergoing colonoscopy, does the use of 
propofol for sedation versus the use of a benzodiazepine and an opioid combination 
decrease the overall cost for patients by decreasing the time until discharge from the post-
anesthesia care unit (PACU)?  Although the combination of a benzodiazepine and an 
opioid has been used for many years and is still used in GI sedation procedures today, 
propofol sedation has a documented quicker induction and recovery time and may 
actually improve patient movement through the GI endoscopy suite (Cohen et al., 2004).  
In this project, recovery and discharge times were measured along with performance of a 
cost analysis to determine which sedation regimen is more cost efficient.  
Problem Statement 
Colonoscopies are typically performed as outpatient procedures, meaning the 
patient will be sent home from the GI endoscopy suite as soon as they meet requirements 
for discharge.  Quick recovery from sedation and fast turnovers are highly desirable in 
settings such as these to increase patient safety and satisfaction, increase revenue, and 
decrease cost.  The optimal sedation regimen has a rapid onset, short duration of action, 
and minimally affects cognition once sedation is terminated (Watkins et al., 2014).  
Discharging patients from the recovery area with lingering sedation could cause 
untoward events once the patient is out of the healthcare provider’s care; therefore, 
sedation with a regimen that has quick induction and recovery times is ideal for 
outpatient procedures such as colonoscopies.  This not only improves patients’ 
satisfaction and safety, but also increases revenue and decreases cost for healthcare 
organizations due to increased efficiency and avoiding accidental injuries such as falls.    
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Purpose of the Project 
The purpose of this project was to determine if there was a difference in cost due 
to the difference in discharge times between patients undergoing colonoscopy in the GI 
endoscopy suite who are administered propofol for sedation versus those who are 
administered a benzodiazepine and an opioid for sedation.  Cohen and Benson (2009) 
report that three colonoscopies can be performed under propofol sedation versus two 
performed under midazolam and meperidine sedation in the same time frame.  With that 
level of efficiency, propofol seems to be the superior method of sedation for patients.  
Quicker recovery time leads to shorter stays in the PACU and decreased costs.   
Most comparative studies have shown that patients prefer sedation with propofol 
 over standard sedation drugs due to the opportunity for painless endoscopy, a very 
 low incidence of post-procedure side effects such as nausea and vomiting, and a 
 rapid return to a clearheaded state upon completion of the procedure (Cohen & 
 Benson, 2009, p. 566).   
Needs Assessment 
With colorectal cancer being the third most common type of cancer in the United 
States and the third leading cause of cancer death, many people rely on screening tools 
for early detection and prevention of this disease (Siegel et al., 2014; USPSTF, 2008).  
“The USPSTF recommends screening for colorectal cancer using fecal occult blood 
testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and 
continuing until age 75 years” (USPSTF, 2008).  Therefore, these procedures are 
common, and many patients present to the GI endoscopy suite each day for 
colonoscopies. Different sedation methods are utilized to facilitate completion of 
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colonoscopies, and significant differences may occur in patient satisfaction and 
efficiency.   
 Although the combination of a benzodiazepine and an opiate is adequate for the 
 large majority of patients, there are drawbacks to the use of these drugs which 
 include the following: a delay of several minutes after injection before the drugs 
 exert their effect, lingering sedative effects that delay discharge, significant cost 
 because of monitoring and prolonged recovery, and morbidity and mortality as a 
 result of respiratory depression (Sipe et al., 2002, p. 815).   
Seventy-five percent of GI procedures are completed under benzodiazepine and opioid 
sedation, but survey data concludes that propofol sedation is increasing (McQuaid & 
Laine, 2008).  Propofol for sedation is an alternative to the common benzodiazepine and 
opioid combination that has resulted in greater satisfaction and decreased recovery time 
(Sipe et al., 2002).  The increase in popularity of propofol sedation may be due to the fact 
that providers believe that both sedation and recovery times are decreased and efficiency 
of the department is improved (McQuaid & Laine, 2008).  Additionally, sedation 
methods have changed due to patients’ expectations of a painless procedure, desire of the 
physician to improve efficiency, and reimbursement from insurance companies for 
anesthesia services (Cohen & Benson, 2009).  Therefore, with superior expectations from 
all stakeholders, utilization of a sedation routine that is safe, time and cost efficient, and 
provides the best comfort for the patient is imperative.   
At the clinical site where this project was implemented, 2895 colonoscopies were 
performed in 2015.  Several factors such as gastroenterologist preference, comorbidities 
of the patient, the patient’s current medication regimen, and patient preference determine 
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whether he or she is sedated with propofol or a benzodiazepine and opioid combination.  
If propofol is found to significantly reduce discharge times and, therefore, costs, a 
practice change could occur, and all sedation in the GI endoscopy suite could be 
performed with propofol.  Additionally, propofol sedation may improve patient 
satisfaction and increase revenue for the organization.   
Theoretical and Conceptual Framework 
Joanne R. Duffy’s The Quality-Caring Model is the framework that was used to 
guide this project.  This theory was developed by Duffy in 2003 because of previous 
experience with nursing care being marginalized since more modern healthcare emphasis 
was placed on tasks, technology, and cost containment (Duffy, 2015).  Quality once 
referred to excellence of a service, but it has since expanded to include safety and value 
and includes advanced practice (Duffy, 2013).   
The Quality-Caring Model holds nurses accountable for developing a caring 
relationship with both patients and families (Duffy, 2015).  “Caring is a process that 
involves the person of the nurse relating with the person of the patient” (Duffy, 2013, p. 
32).  In addition, a collaborative relationship with other healthcare providers is also the 
responsibility of the nurse so the best interest of the patient and their family is always 
upheld (Duffy, 2015).  This model is an outstanding guide for this project because 
advanced practice nurses must develop a caring relationship with patients and families 
while developing a plan of care between providers that maintains and improves the 
patient’s health by utilizing the most cost-efficient sedation regimen.  By providing a 
sedation technique to patients undergoing colonoscopy that enables them to recover 
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quickly while decreasing costs, both a caring and collaborative relationship has been 
exhibited.   
Adhering to a caring relationship with patients also means that the advanced 
practice nurse provides cost-efficient care.  A cost-effective analysis explores health 
outcomes in relation to treatment or intervention (Butts & Rich, 2015).  Advanced 
practice nurses are vitally aware that economic decisions not only affect their practice, 
but also the lives of their patients (Butts & Rich, 2015).   
 Any discussion of the situation of healthcare begins with the process of 
 collecting data on soaring costs, calling into question whether higher costs are 
 related to higher quality, and making dire predictions of the consequences of 
 failing to control costs (Butts & Rich, 2015, p. 320).   
If patients in endoscopy suites are administered only propofol instead of benzodiazepines 
and opioids, and their discharge times decrease due to enhanced recovery, costs are 
decreased, profit is increased for the facility, and satisfaction remains high. 
The Quality-Caring Model and cost analysis tie this project together completely 
because APRNs, such as CRNAs, have the duty to provide care for patients that is both 
high quality and cost efficient.  Many patients deter from preventative services, such as 
colonoscopies, because they simply cannot afford them.  By implementing cost 
containment while providing high-quality healthcare for patients, ideally more patients 
will become compliant with healthcare standards, and the overall population will become 
healthier.  The Institute for Healthcare Improvement (IHI) developed the Triple Aim 
framework that mandates healthcare must be compliant in three dimensions of (1) 
improving the patient experience (i.e. quality and satisfaction), (2) improving population 
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health, and (3) reducing the cost of healthcare (IHI, 2017).  Duffy’s Quality-Caring 
Model and a cost-effective analysis exude the three dimensions of the Triple Aim 
framework that the IHI has mandated for modern healthcare.    
DNP Essentials 
There are eight essential elements to the Doctor of Nursing Practice (DNP) degree 
(AACN, 2006).  Each of those eight essentials was met in the development of this project 
and are listed as follows:   
• Essential I, Scientific Underpinnings for Practice, was met by completing a 
literature review of the topic, exploring the scientific knowledge previously 
discovered, and conducting an evidence-based project.  “DNP prepared advanced 
practice nurses bring specific expertise to their work, based on a very particular 
grounding in the scholarship of application” (Zaccagnini & White, 2014, p. 4).   
• Essential II, Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking, was met because determination of which sedation practice 
decreases cost effects the entire system of both the patient’s experience and the 
anesthesia provider’s care.   
• Essential III, Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice, was met by conduction of a thorough literature review and a quantitative 
analysis on the subject of sedation practices in the GI endoscopy suite.   
• Essential IV, Information Systems/Technology and Patient Care Technology for 
the Improvement and Transformation of Health Care, was met by utilizing the 
facility’s information system and collaborating with the Information Technology 
(IT) personnel to retrieve data for the project.  “The framework for the steps and 
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skills needed for providing the best patient care in a technology-rich environment 
includes the ability to use critical thinking and assessment skills to determine 
what information is needed” (Zaccagnini & White, 2014, p. 141).   
• Essential V, Health Care Policy for Advocacy in Health Care, was met because 
the results of this project will help the organization develop policies to improve 
the delivery of healthcare by reducing costs in the GI endoscopy suite.   
• Essential VI, Inter-professional Collaboration for Improving Patient and 
Population Health Outcomes, was met by collaborating with other healthcare 
professionals regarding best sedation practices for the GI endoscopy suite and 
determination of the best outcomes for colonoscopy patients.   
• Essential VII, Clinical Prevention and Population Health for Improving the 
Nation’s Health, was met because colonoscopies are essential to reducing the 
incidence and fatalities of colorectal cancer.  By discovering the best sedation 
practice for the colonoscopy patient, ideally, more compliance will be attained.   
• Essential VIII, Advanced Nursing Practice, was met because certified registered 
nurse anesthetists (CRNAs) are key stakeholders in this project as they perform 
sedation in the GI endoscopy suite and require evidence-based information on 
which to base best practice.   
Although advanced practice nurses are not expected to be experts in all areas of nursing, 
DNP programs provide the preparation that allows their graduates to be experts in their 
own field of nursing (AACN, 2006) (See Appendix A). 
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CHAPTER II – REVIEW OF RELATED LITERATURE 
A literature search was performed to explore the difference in discharge times of 
patients sedated with propofol versus patients sedated with a benzodiazepine and an 
opioid combination for colonoscopy.  Several databases including CINAHL with Full 
Text, Medline, PubMed, Cochrane, and Google Scholar were searched for relevant 
articles.  The following search terms were utilized: colonoscopy, endoscopy, sedation, 
propofol, benzodiazepine, and opioid.  An initial search with limitations to full text only 
and publication dates between 2001 and 2016 returned 114 articles after duplications 
were removed.  Upon further review of all databases accessed, 12 articles were selected 
because they were strongly applicable to this project.  A literature matrix is included with 
information from each of the included articles (See Appendix B).     
Sedation Considerations for Colonoscopy 
In order for patients to be comfortable during procedures such a colonoscopies, 
sedation is required.  Several factors such as anxiety, abdominal distention during 
insufflation, and endoscope manipulation cause patients discomfort that can be avoided 
with sedation (Nagelhaut & Plaus, 2014).  Although some patients will tolerate the 
colonoscopy using moderate sedation without difficulty, others will require deep sedation 
to be comfortable.  However, there are no strict boundaries in sedation as it may progress 
in depth to the next level without intent from the provider (Nagelhaut & Plaus, 2014).  
The provider administering sedation must be extremely vigilant in monitoring the patient 
for progression and be able to rescue the patient from each depth should the need arise. 
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Moderate Sedation 
Moderate (conscious) sedation, which is now administered by Registered Nurses 
(RNs) or Advanced Practice Registered Nurses (APRNs), was once solely administered 
by anesthesia providers (Caperelli-White & Urman, 2014).  The American Society of 
Anesthesiologists (ASA) defines moderate sedation as 
 … a drug induced depression of consciousness during which patients respond 
 purposely to verbal commands, either alone or accompanied by light tactile 
 stimulation.  No interventions are required to maintain a patent airway, and 
 spontaneous ventilation is adequate.  Cardiovascular function is usually 
 maintained (Caperelli-White & Urman, 2014, p. 416).   
Administration of moderate sedation to patients is a significant responsibility regardless 
of the setting or provider.  These patients need to be monitored closely because sedation 
always has the potential to become deeper than the provider intended.  The American 
Association of Nurse Anesthetists (AANA) and the Mississippi Board of Nursing 
(MSBON) declares that the RN providing conscious sedation to the patient should have 
no other responsibilities than drug administration and monitoring of the patient during the 
procedure (Caperelli-White & Urman, 2014; MSBON, 2009).  Any other responsibilities 
or tasks could easily distract the RN, or other provider, from the patient and untoward 
events occur.  Additionally, some institutions and boards of nursing require that 
professionals administering moderate sedation have additional education and training in 
the clinical and administrative aspects of sedation (Caperelli-White & Urman, 2014; 
MSBON, 2009).   
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Deep Sedation 
Progression from moderate sedation to deep sedation causes different physiologic 
responses to occur.  Instead of immediately responding to verbal or tactile stimulation, 
the patient may require repeated or even painful stimulation to become arousable 
(AANA, 2016; Obara et al., 2015).  In deep sedation, spontaneous ventilation may be 
inadequate, and intervention may be required to maintain a patent airway; however, 
cardiovascular function is typically maintained (AANA, 2016; Obara et al., 2015).  
Rescue from deep sedation requires providers proficient in airway management because 
respiratory depression and airway obstruction hold a high incidence in patient death for 
those undergoing sedation for endoscopy (Obara et al., 2015).  Furthermore, the 
incidence of airway emergencies (i.e. airway obstruction, respiratory depression) is twice 
as high outside the operating room in remote locations, such as GI endoscopy suites 
(Obara et al., 2015). 
Monitored Anesthesia Care 
Monitored anesthesia care (MAC) is an anesthetic technique in which an 
anesthesia provider conducts a preoperative assessment, develops a plan for sedation, 
administers care during the procedure, and manages the patient postoperatively (ASA, 
2013; Miller & Pardo, 2011).  “An ideal anesthetic technique would incorporate optimal 
patient safety and satisfaction, provide excellent operating conditions for the surgeon, 
allow rapid recovery, and avoid postoperative side effects” (Miller & Pardo, 2011, p. 
191).  The ASA states that MAC includes varying levels of sedation, analgesia, and 
anxiolysis, therefore, this technique is limited to anesthesia providers so that conversion 
to a general anesthetic and airway management is feasible should the need arise (ASA, 
 13 
2013; Das & Ghosh, 2015).  Drugs ideal for sedation should have a rapid onset and 
clearance, be easy to titrate, and have minimal side effects, especially lacking 
cardiovascular and respiratory depression (Das & Ghosh, 2015).  Propofol produces a 
more rapid, clear-headed recovery and protects against postoperative nausea and 
vomiting (PONV) than does midazolam and opioid combinations, making it an ideal drug 
for sedation (Das & Ghosh, 2015).  Even though midazolam has a short elimination half-
life, it causes prolonged psychomotor impairment and when used with an opioid, severe 
cardiovascular and respiratory depression can be seen (Das & Ghosh, 2015). 
Mississippi’s Position Statement on Sedation 
Each state has its own position statement regarding the administration and 
monitoring of patients under each level of sedation.  Mississippi’s position statement 
reads that even though optimal anesthesia care is best provided by anesthesiologists and 
CRNAs, the high clinical demand for intravenous (IV) sedation permits non-CRNA RNs 
to administer moderate sedation (MSBON, 2009).  RNs are not allowed by the 
Mississippi State Board of Nursing to administer deep sedation, general anesthesia, or 
any pharmacologic agents that are used in the administration of general anesthesia 
(MSBON, 2009).  For the RNs providing moderate sedation to patients, the Mississippi 
State Board of Nursing deems it necessary for those providers to obtain additional 
education from their facilities in the administration, monitoring, and management of 
sedated patients (MSBON, 2009).  In addition, the anesthesia provider, attending 
physician, or CRNA who ordered the sedation for the patient must be physically present 
and immediately available should an emergency arise (MSBON, 2009). 
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Propofol 
Propofol, a sedative-hypnotic, is one of the newest anesthetic induction drugs, 
first introduced into clinical practice in 1989, and has since become the drug of choice for 
many anesthesia aspects (Ouellette & Joyce, 2011).  The mechanism of action of 
propofol is exerted primarily by effect on gamma-aminobutyric acid (GABA) receptors 
(Ouellette & Joyce, 2011).  GABA is the primary inhibitory neurotransmitter of the 
central nervous system (CNS), and activation of GABA receptors by propofol causes an 
increase of chloride transmembrane conduction causing a hyperpolarization of the cell to 
occur and inhibition of the neuron (Ouellette & Joyce, 2011).  One of the more desirable 
effects of propofol that makes it different from other anesthesia drugs is a rapid and 
complete reawakening that occurs because propofol redistributes away from the effect 
site (brain) to other tissues that are not as well perfused (muscles) (Ouellette & Joyce, 
2011).  Additionally, the metabolic clearance of propofol exceeds hepatic blood flow, 
which suggests an extra-hepatic metabolic pathway; pulmonary uptake and elimination of 
propofol is possibly an extra-hepatic metabolic pathway (Ouellette & Joyce, 2011).  
Although propofol is metabolized extensively and rapidly by the hepatic system, and 
renal elimination is dominant, there is no evidence that neither hepatic nor renal 
dysfunction impacts the rapid redistribution and quick reawakening associated with 
propofol (Ouellette & Joyce, 2011).  Another desirable effect of propofol, regardless of 
the anesthetic technique, is its anti-emetic properties that decrease the occurrence of 
PONV (Ouellette & Joyce, 2011). 
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Fentanyl 
Fentanyl is an opioid that provides analgesia by stimulating 𝜇 receptors (Ouellette 
& Joyce, 2011). The rapid onset and short duration of action make fentanyl an ideal drug 
for use in anesthesia (Ouellette & Joyce, 2011).  Pharmacokinetics associated with 
fentanyl are distribution time 1.7 minutes, redistribution time 13 minutes, and half-life 
219 minutes (Ouellette & Joyce, 2011).  The onset of action of fentanyl is almost 
immediate, and the duration of effects typically lasts 30 minutes to one hour (Ouellette & 
Joyce, 2011).  Fentanyl is metabolized in the liver by the cytochrome P 450 (CYP) 
system, and up to 75% is eliminated in the urine as the original drug (Ouellette & Joyce, 
2011). 
Meperidine 
Meperidine is a synthetic opioid that is used in moderate sedation.  Meperidine is 
a derivative of the phenylpiperidine group with a half-life of 2.5 to 4 hours that is 
significantly increased by renal failure (Miller & Pardo, 2011).  The metabolite of 
meperidine, normeperidine, also produces analgesia, central nervous system (CNS) 
excitability, and seizures (Miller & Pardo, 2011; Ouellette & Joyce, 2011).  Additionally, 
the chemical structure of meperidine is similar to atropine, which causes increased heart 
rate (Butterworth, Mackey, & Wasnick, 2013).  Meperidine should not be used in patients 
with renal failure or CNS disturbances (Ouellette & Joyce, 2011).    
Midazolam 
Midazolam is a benzodiazepine drug that produces anterograde amnesia from the 
time of injection and typically lasts through the recovery period (Ouellette & Joyce, 
2011).  It produces strong sedative effects and quick recovery, making it the most 
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commonly used benzodiazepine for sedation (Ouellette & Joyce, 2011).  The effects of 
midazolam are exerted by binding to GABAa receptors, opening the chloride channels for 
extensive periods, hyperpolarizing the cells, and making the cell less excitable (Ouellette 
& Joyce, 2011).  Of the benzodiazepine drugs in clinical use, midazolam is the best 
choice because of its higher clearance level (6-8 ml/kg/min) (diazepam or lorazepam- 
0.2-1 ml/kg/min) (Ouellette & Joyce, 2011).  Metabolism of midazolam occurs in the 
hepatic system due to the CYP 450 system, and it is eliminated by the renal system 
(Ouellette & Joyce, 2011).  The active metabolites of midazolam are quickly conjugated 
so that no secondary effects of the drug are exhibited; whereas, the effects of diazepam 
can be seen up to 20 hours after administration (Ouellette & Joyce, 2011).  However, 
midazolam does cause greater respiratory depression than other benzodiazepines 
(Ouellette & Joyce, 2011). 
Comparison of Sedation Regimens 
In the past, researchers have studied the difference in recovery and discharge 
times of patients who were sedated for procedures in the GI endoscopy suite and found 
that propofol is superior to a benzodiazepine and opioid combination for sedation because 
it allows improved sedation, faster recoveries, and higher efficiency of department 
function (Poulos, Kalogerinis, & Caudle, 2013).  Poulos et al. (2013) performed a 
retrospective cohort trial that studied 951 patients undergoing colonoscopy or 
esophagogastroduodenoscopy (EGD) from 2007 to 2010 that were sedated either with (1) 
propofol, (2) midazolam, fentanyl, and propofol, or (3) midazolam and fentanyl.  After 
the study was completed, findings indicated that sedation with propofol resulted in 
quicker inductions, shorter procedures, and faster recoveries than patients who were 
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sedated with (1) midazolam, fentanyl, and propofol or (2) midazolam and fentanyl 
(Poulos et al., 2013).   
Sipe et al. (2002) published a randomized, blinded, prospective study of 80 
patients undergoing colonoscopy under sedation either with (1) propofol or (2) 
midazolam and meperidine.  The mean times until sedation, recovery, and discharge were 
quicker by an average of 34 minutes in the propofol group (Sipe et al., 2002).  In addition 
to providing more time efficient sedation and recovery, both patient and nurse 
satisfaction was greater among the propofol group.  Nurses involved in this study 
reported that the level of sedation was adequate in 100% of propofol patients, whereas it 
was only adequate in 90% of the midazolam and meperidine patients (Sipe et al., 2002).  
When surveyed, 100% of patients in the propofol group were satisfied with their 
sedation, whereas five patients from the midazolam and meperidine group reported that 
their sedation could have been adjusted, either more or less (Sipe et al., 2002). 
Synthesis of the Literature 
From the literature reviewed for this project, all authors concluded that propofol 
was superior to other methods of sedation for quicker recovery and discharge times from 
the PACU.  The decrease in time required for recovery may assist to decrease overall 
costs for patients and increase revenue for organizations, however, other factors such as 
anesthesia provider cost for administration of propofol versus RN administration of a 
benzodiazepine and an opioid must be considered.  Both methods of sedation are safe and 
effective; however, patient satisfaction tends to be higher with propofol.  Different 
organizations must conduct their own cost-benefit analysis to determine if the time saved 
is beneficial even with the cost of anesthesia provider administration of propofol.   
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CHAPTER III  - METHODOLOGY 
Target Outcomes 
The target outcome of this study was to determine if decreased costs are seen in 
patients who are administered propofol for sedation rather than a benzodiazepine and 
opioid combination to facilitate colonoscopy in the GI endoscopy suite.  Previous studies 
have indicated that using propofol for sedation quickens recovery of patients and prepares 
them for discharge sooner (Poulos et al., 2013; Sipe et al, 2002; Vargo et al., 2002).  The 
outcome was determined by comparing the difference in discharge times, cost for 
provider administration of sedation (anesthesia provider or RN), and cost of drugs that 
are administered for sedation between patients who are sedated with propofol and those 
sedated with midazolam and fentanyl/meperidine in a GI endoscopy suite (See Appendix 
C and D, Logic Model and SWOT Analysis). 
Setting 
The clinical setting for this project was a GI endoscopy suite at a 215-bed acute 
care facility in rural Mississippi.  This was an optimal setting to study the difference in 
discharge times between patients sedated with propofol versus the patients sedated with a 
benzodiazepine and opioid combination because, on a daily basis, many patients are seen 
in this particular GI endoscopy suite and are sedated with propofol or a benzodiazepine 
and opioid combination.  At this clinical site, both EGDs and colonoscopies are 
performed daily, but for this project, only colonoscopies were studied.  
Population and Sample 
This project utilized a retrospective chart review of patients ASA physical status 
(PS) I or II and ages 18 to 55 (See Appendix E, ASA PS Classification).  Based on a G-
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Power Analysis, for a moderate effect size, a total of 176 charts were needed with 88 in 
each group (Buchner, Erdfelder, Faul, & Lang, 2007).  These charts were selected from 
cases January 1, 2015, through December 31, 2015, in the GI endoscopy suite at the acute 
care facility mentioned above.  Exclusion criteria included the following: ASA-PS III or 
IV, non-English speaking, pregnancy, allergy to eggs, fentanyl, or midazolam, previous 
neurological deficit, patients scheduled for colonoscopy and EGD in the same day, 
hospital inpatients undergoing colonoscopy, and patients undergoing emergency 
procedures.  Sampling for this project was achieved by a convenience sample 
retrospective chart review of previous colonoscopies where all patient criteria had been 
met.   
Barriers 
A potential barrier to this project was disinterest of the gastroenterologists and GI 
endoscopy suite staff where this project took place.  Without the interest and support of 
the providers who administer the daily bedside care, gaining approval for this project 
from administration would not have been possible.  Educating the physicians and staff 
that the results of this project could help to improve efficiency and thereby reduce costs 
in the future were explained to help gain their interest.  The goal of this project was to 
determine which sedation regimen is most cost-effective and provides quicker discharge 
times for patients as well as the potential for increased throughput in the department.   
Statistical Analysis 
For patients in the GI endoscopy suite undergoing colonoscopy, does the use of 
propofol for sedation versus the use of a benzodiazepine and an opioid combination 
decrease the overall cost for patients by decreasing the time until discharge from the post-
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anesthesia care unit (PACU)?  The null hypothesis was that there were no significant 
differences between the two groups on discharge times after completion of the 
colonoscopy.  The hypothesis was that the propofol group would be discharged 
significantly quicker than the benzodiazepine and opioid combination group.  
Significance was set apriori at less than or equal to 0.05.  For this study, a one-tailed 
independent t-test was used to determine statistical significance.  An independent t-test is 
used for statistical analysis when two different groups (people, things, etc.) are being 
compared on the same dependent variable (Frey, 2016).  A one-tailed t-test was used 
because of the directionality of the hypothesis.  In this project, two different groups of 
patients were studied, and the particular interest was the difference in mean discharge 
times from PACU after sedation for colonoscopy.  A chi-square test was performed to 
examine whether demographic data differences from each group may explain t-test 
results.  Chi-square tests compare the occurrences in each category to the hypothesized 
outcome (Frey, 2016). 
Collection of Data 
In this project, the independent variable was the method of sedation, both 
propofol and benzodiazepine and opioid combination.  The dependent variable was the 
discharge time from PACU, with the resulting cost associated with provider cost for 
administration of sedation, and cost of drugs used for sedation.  Data collected were ASA 
PS, age, gender, type of sedation, time of sedation start and end, time of procedure start 
and end, time until discharge from PACU in minutes, cost of provider administration of 
sedation, and cost of each drug used for sedation.  The time of procedure end to discharge 
from the PACU in minutes was the time that was analyzed.  Once data were collected and 
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the statistical analysis was performed, results were presented to anesthesia providers in 
the facility where the project was conducted.  An informal interview was conducted with 
anesthesia providers to gain their insight on results of this project and how to ensure the 
GI endoscopy suite can become both time and cost efficient. 
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CHAPTER IV – RESULTS 
Analysis of Data 
For this DNP project, 3595 charts were reviewed and 176 were included in this 
study per recommendation of the G power analysis previously performed by the 
researcher.  The 176 charts were chosen by a convenience sample on a first come, first 
serve basis beginning with records from January 2015, until 88 charts meeting the 
inclusion criteria were in each group.  Patients included in this project were ASA PS I or 
II with a minimum age of 18 years, a maximum age of 55 years, and a mean age of 45.9 
years.  There were 115 females and 61 males who met inclusion criteria.  Of the 176 total 
patients included, 161 were ASA PS II and 15 were ASA PS I. 
Table 1  
Demographical Data 
 Propofol group Benzodiazepine and 
opioid group 
Total 
Gender    
Male 32 29 61 (34.7%) 
Female 56 59 115 (65.3%) 
ASA    
ASA PS I 4 11 15 (8.5%) 
ASA PS II 84 77 161 (91.5%) 
Age (in years)    
Minimum 18 20  
Maximum 55 55  
Mean 44.4 47.3  
 
 A one-tailed independent sample t-test was utilized to determine differences 
between the two different methods of sedation since the researcher hypothesized that 
sedation with propofol would render faster discharge times from PACU.  There were no 
significant outliers or missing data, and all data were both valid and reliable (i.e. no 
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incorrect data were transposed into statistical analysis).  A statistically significant 
difference was found between the discharge times in minutes of the two different groups 
of patients (group propofol M= 80.99, SD= 15.36 and group benzodiazepine and opioid 
M= 84.58, SD= 13.42) (p= 0.05).  The results of this analysis accept the hypothesis that 
propofol sedation for patients undergoing colonoscopy in the GI endoscopy suite renders 
quicker discharge times than does sedation with a benzodiazepine and an opioid.  
Table 2  
Mean Sedation, Procedure, and PACU Times 
 Propofol Benzodiazepine and opioid 
Sedation time 23.53 minutes 9.16 minutes 
Procedure time 16.93 minutes 23.59 minutes 
PACU time 75.5 minutes 81.26 minutes 
 
A chi-square (2) test was performed on the demographical data of patients 
included in this project to ensure that differences in demographics did not affect results of 
the analysis.  The demographical data included in the chi-square test were age, gender 
(male and female), and ASA PS (I and II) classification.  Results of this test confirmed 
the null hypothesis that no statistically significant differences in demographical data were 
present that may have affected the difference in discharge times between the two sedation 
groups (2(4)= 3.87, p< 0.05).    
Cost Analysis 
A cost analysis was performed on variables of this DNP project including the cost 
of PACU time in minutes, cost of administration of sedation by anesthesia providers 
versus RNs, and cost of common drugs used for sedation.  The costs included in Table 3 
and Table 4 are the major costs but are only part of what is billed to patients after having 
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a colonoscopy.  Additionally, CRNA salaries are higher than salaries of RNs, which can 
be a major cost to the facility.  The visual cost analysis confirmed that administration of 
propofol by anesthesia providers is more costly ($640.38) than moderate sedation with a 
benzodiazepine and an opioid administered by a RN (414.77 to $415.77).  
  Upon further investigation of reimbursement for colonoscopies, the mean 
collected monies at the facility where this project was performed are $939.92 regardless 
of which type of sedation was provided.  Even though the total dollar amount billed to the 
patient is more for anesthesia provided sedation with propofol ($640.38), the same 
amount is collected on colonoscopies with either type of sedation.  Therefore, since 
propofol is more time efficient, there is potential that increased throughput of patients and 
overall increased number of patients able to be seen could result in increased revenue for 
the facility.   
Table 3  
MAC cost—provided by anesthesia providers 
Variable Cost per unit Meantime/dose Total mean cost 
MAC $250.00 flat fee then 
$50.00/15 minutes 
9.16 minutes $280.53 
Propofol 10mg/ml 
(50ml) 
$76.35 210mg $76.35 
PACU $283.50 
(indefinitely) 
--- $283.50 
Total Cost   $640.38 
Average reimbursement for colonoscopies for both types of sedation is $939.92 
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Table 4  
Moderate sedation cost—provided by RNs 
Variable Cost per unit Meantime/dose Total mean cost 
Moderate Sedation $20.00/ 15 minutes 23.53 minutes $31.37 
Midazolam 2mg/2ml 
(2ml) 
$16.65 7.01mg  $66.60 
Meperidine 50mg/ml 
(1ml) 
$17.15 69.55mg $34.30 
Fentanyl 50mcg/ml 
(2ml) 
$16.65 130mcg $33.30 
PACU $283.50 (indefinitely) --- $283.50 
Total Cost   $414.77 or 
$415.77 
Average reimbursement for colonoscopies for both types of sedation is $939.92 
For moderate sedation either midazolam and meperidine or midazolam and fentanyl are given together. 
Presentation of Results to Anesthesia Providers 
After the statistical and cost analyses, results were informally presented to 
anesthesia providers in the facility where this project was performed.  Anecdotal 
feedback provided valuable insight into how project findings were processed by the 
anesthesia providers.  Anesthesia providers agreed that while MAC with propofol is 
necessary for certain patients, it may not be the most cost effective method of sedation in 
the GI endoscopy suite.  Anesthesia provided sedation costs the facility more than does 
moderate sedation by RNs (CRNA salary versus RN salary).  However, if propofol 
sedation is going to be delivered, patients should be discharged from PACU when 
discharge criteria are met so patient throughput is increased.  Anesthesia providers agreed 
that if discharge time for propofol sedation was decreased, by adhering to protocols in 
place, more patients could be seen, and more revenue could be captured, particularly 
since reimbursement is the same for both methods of sedation.   
 26 
Conclusion 
The purpose of this DNP project was to determine which sedation regimen was 
both more time and cost efficient for patients undergoing colonoscopy in the GI 
endoscopy suite.  Results of analyses were found to conclude that while propofol sedation 
was more time efficient, sedation with a benzodiazepine and opioid was more cost 
efficient.  Although the literature suggested that propofol sedation is more time and cost 
efficient, there were limitations specific to the clinical site that may have influenced the 
results of this DNP project.  These are presented in the Discussion. 
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CHAPTER V – DISCUSSION 
Limitations 
Limitations were present while conducting this project.  One limiting factor was 
that the project was a retrospective chart review that utilized convenience samples of 
data.  Charting errors, illegible handwriting of providers, and coding errors potentially 
resulted in data reliability issues.  Other limiting factors of this project are clinical site-
specific procedures.  In the acute care facility where this project was conducted, most 
patients undergoing sedation for GI procedures were kept in PACU for 60 minutes or 
greater regardless of when discharge criteria were met.  Additionally, the 
gastroenterologist who performed the procedure made rounds on each patient after his or 
her endoscopy procedure before he or she was allowed to be discharged.  After 
discussion with PACU RNs at this facility, the procedure to keep patients for 60 minutes 
has changed since this project.  Currently, PACU RNs are attempting to discharge 
patients sedated with propofol within 30 minutes if all discharge criteria are met and he 
or she has been seen by the gastroenterologist.  Moderate sedation patients are still kept 
in PACU 60 minutes before discharge.     
Benefits 
Retrospective chart reviews are beneficial because all medical records are readily 
accessible and data is easily collected.  Challenges of performing a prospective project 
are eliminated with gathering of data from previous cases.  No additional costs, resources, 
time, or procedures were required of the staff in the GI endoscopy suite for facilitation of 
this project. 
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Theoretical Model Applied to This Project 
The two frameworks that were used to guide this project were Duffy’s Quality-
Caring Model and cost efficiency.  While providing high-quality care is first and 
foremost when caring for patients, APRNs, such as CRNAs, have to duty to also provide 
cost efficient care.  Safety and value are now included in quality care (Duffy, 2015).  In 
this project, both time and cost efficiency were compared for two different methods of 
sedation.  While one method was found to be more time efficient, and the other method 
was found to be more cost efficient, the provider must determine which method is most 
suitable for the patient.  Quality care and cost efficiency can be delivered together in most 
cases.  However, there are times that the best plan for the patient is not the least 
expensive, and times when the most expensive is not the best plan.  Each patient has to be 
evaluated for who he or she is and what he or she needs.  Duffy’s Quality-Caring Model 
epitomizes providing individualized care that is of highest quality for each patient.  
However, cost does affect patients, and performance of a cost-effective analysis allows 
the CRNA to deliver quality healthcare that is cost effective so that patients can afford to 
receive care that will facilitate his or her treatment or intervention.  Delivery of high-
quality, low-cost healthcare is a skill that is made possible with evidence-based practice.   
Implications for Future Practice 
Future projects should be conducted in this setting to determine if the change in 
PACU time before discharge, by following new unit protocols significantly impacted and 
decreased the mean propofol discharge time of 80.99 minutes.  Cost of facility operations 
such as staffing costs (PACU RNs) and throughput of patients, 2.7 versus 1, may be 
significant enough for the facility to consider utilizing anesthesia providers for MAC for 
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all patients undergoing colonoscopies in the GI endoscopy suite.  Decreased time until 
discharge with propofol could increase the overall number of patients in one day and 
increase the revenue gained for the facility.  Additionally, examining patient satisfaction 
between the two sedation methods could be considered.  Patient satisfaction drives 
reimbursement of healthcare facilities today, and increased satisfaction equals increased 
reimbursement (Berkowitz, 2016). 
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APPENDIX A – DNP Essentials 
Table A1.  
DNP Essentials 
Essential I Scientific Underpinnings for 
Practice 
Conduction of a 
literature review, 
exploration of previous 
scientific knowledge, 
and conducting 
evidence-based study 
Essential II Organizational and Systems 
Leadership for Quality 
Improvement and Systems 
Thinking 
Determination of which 
sedation decreases 
costs effects the entire 
systems of both the 
patient’s experience 
and the anesthesia 
provider’s care 
Essential III Clinical Scholarship and 
Analytical Methods for 
Evidence-Based Practice 
Conduction of a 
literature review and a 
quantitative analysis 
Essential IV Information 
Systems/Technology and Patient 
Care Technology 
Utilization of the 
facility’s information 
system and cooperation 
with the IT department 
for retrieval of 
information 
Essential V Health Care Policy for Advocacy 
in Health Care 
The results of this 
project will guide new 
policies in the GI 
endoscopy suite 
Essential VI Interprofessional Collaboration 
for Improving Patient and 
Population Health Outcomes 
Collaboration with 
other healthcare 
professionals for the 
best sedation regimen 
to decrease cost and 
discharge times for 
colonoscopy patients in 
the GI endoscopy suite  
Essential VII Clinical Prevention and 
Population Health for Improving 
the Nation’s Health 
Determination of which 
sedation practice 
decreases costs and 
enhances recovery to 
gain compliance of 
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patients that meet 
requirements for 
screening 
colonoscopies 
Essential VIII Advanced Nursing Practice CRNAs are APRNs 
that deliver sedation to 
patients undergoing 
colonoscopy in the GI 
endoscopy suite 
(AACN, 2006; Zaccagnini & White, 2014) 
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APPENDIX B – Literature Matrix 
Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Caperelli-White, L. 
and Urman, R. D. 
(2014). “Developing a 
moderate sedation 
policy: essential 
elements and 
evidence-based 
considerations.” 
Level 4/Grade 
D 
Expert opinion/ 
Commentary 
N/A Policies and 
procedures 
should guide 
how and by 
whom sedation 
is performed.  
Policies should 
follow practice 
laws when 
determining 
which 
medications can 
be administered 
by whom and 
the type of 
monitoring 
equipment 
utilized.  Pre-
procedure 
assessments 
must be 
performed as 
well as post-
procedure 
recovery plans 
implemented.  
N/A Each facility must 
establish their own 
policies and 
procedures regarding 
sedation practice that 
aligns with evidence-
based practice and 
abides by practice 
laws for the 
disciplines. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Cohen, L. B., and 
Benson, A. A. 
(2009). “Issues in 
Endoscopic 
Sedation.” 
Level 4/Grade 
D 
Expert 
opinion/Commentary 
N/A MAC 
decreases 
time in the 
procedure for 
patients and 
increases 
their 
satisfaction 
with the 
procedure.  
Also, new 
drugs such as 
fospropofol 
and new 
methods such 
as computer 
assisted and 
patient 
controlled 
sedation are 
options for 
sedation 
methods in 
the GI lab.  
N/A More outcome 
studies need to be 
performed with 
endoscopist-directed 
sedation using 
propofol. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Cohen, L. B., Hightower, 
C. D., Wood, D. A., 
Miller, K. M., and 
Aisenberg, J. (2004). 
“Moderate level sedation 
during endoscopy: a 
prospective study using 
low-dose propofol, 
meperidine/fentanyl, and 
midazolam.” 
Level 2+/ 
Grade C 
Cohort study 100 consecutive 
patients, who 
met inclusion 
criteria, that 
presented either 
for EGD or 
colonoscopy 
and were 
sedated with 
propofol, 
midazolam, and 
fentanyl (or 
meperidine) 
were studied at 
intervals to 
determine the 
depth of 
sedation (mild, 
moderate, deep) 
that occurred 
during the 
procedure and if 
propofol could 
be administered 
without entering 
deep sedation. 
Of the 100 patients 
studied, 76 
colonoscopies and 
26 EGDs, the 
surveyor found that 
77% of patients 
were minimally 
sedated, 21% were 
moderately sedated, 
and only 2% 
entered deep 
sedation.  They 
concluded that 
sedation with low-
dose propofol, a 
narcotic, and 
midazolam 
produces moderate 
sedation.  
This study only 
looked at one 
group of patients 
and did not have 
a comparison 
group.  The 
study was 
limited to 
determine 
whether the 
addition of 
propofol to the 
sedation regimen 
of midazolam 
and a narcotic 
would actually 
decrease 
recovery time 
while allowing 
moderate 
sedation to 
ensue. 
The researchers feel 
that the addition of 
propofol to midazolam 
and an opioid for 
sedation improves 
recovery and turnover 
times without the 
patient experiencing 
deep sedation.  
However, they 
recognize that 
randomized, controlled 
trials need to be 
performed before 
making conclusions. 
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Author/Year/Titl
e 
Level/Grad
e 
Design Sample/Dat
a Collection 
Findings Limitation
s 
Recommendation
s 
Das, S. and Ghosh, 
S. (2015). 
“Monitored 
anesthesia care: An 
overview.” 
Level 4/Grade 
D 
Expert 
Opinion/Commentar
y 
N/A MAC is an 
anesthesia 
technique that 
leaves the patient 
spontaneously 
breathing and 
preserves airway 
reflexes while 
offering sedation 
and analgesia for 
procedures.  This 
articles also 
provides 
information on 
propofol and 
dexmetatomidine
, two popular 
drugs that are 
administered 
during MAC.  
N/A The author 
recommended that 
clinicians discern 
which patients are 
right for MAC and 
which are not. Also, 
research on different 
techniques for 
pediatric and 
geriatric populations 
needs to performed 
to offer a 
recommendation for 
those populations. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Lera dos Santos, M. E., 
Maluf-Filho, F., Chaves, 
D. M., Matuguma, S. E., 
Ide, E., Luz, G. de 
 O., de Souza, T. 
F., Pessorrusso, F. C. M., 
de Moura, E. G. H., and 
Sakai, P. (2013). “Deep 
sedation during 
gastrointestinal 
endoscopy: Propofol-
fentanyl and midazolam-
fentanyl regimens.” 
Level 1+/Grade 
A 
Prospective, 
single-blind, 
randomized 
controlled trial. 
200 patients 
were recruited 
and were 
randomly 
placed into 2 
groups.  Those 
2 groups were 
sedation with 
either propofol 
and fentanyl or 
midazolam and 
fentanyl.   
In the propofol 
and fentanyl 
group, times to 
induction of 
sedation, 
recovery, and 
discharge were 
shorter than the 
midazolam and 
fentanyl group.  
Deep sedation 
occurred in 25% 
of propofol and 
fentanyl group 
and 11% of 
midazolam and 
fentanyl group 
according to 
OAA/S scale.  
According to the 
BIS monitor, 
11% of patients 
in the propofol 
and fentanyl 
group were 
deeply sedation 
compared to 7% 
of the midazolam 
and fentanyl 
group. 
This study 
included only 
patients who 
fall into the 
ASA I or II 
class.  Those 
patients are 
relatively 
healthy.  This 
limits the 
validity of the 
study when 
discussing 
patients with 
comorbidities 
that make 
them ASA III 
or greater. 
The 
recommendations 
of the authors of 
this study is that 
patients ASA I or 
II can be safely 
administered 
propofol and 
fentanyl for 
conscious sedation 
for upper 
endoscopy.  They 
also state that the 
presence of an 
anesthesiologist is 
not mandatory for 
the administration 
of this drug.  
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Mandel, J. E., Tanner, 
J. W., Lichtenstein, G. 
R., Metz, D. C., 
Katzka, D. A., 
Ginsberg, G.  G., 
Kochman, M. L. 
(2008). “A 
randomized, controlled, 
double-blind trial of 
patient-controlled 
sedation with 
propofol/remifentanil 
versus 
midazolam/fentanyl for 
colonoscopy.” 
Level 1++/ 
Grade A 
Randomized, 
controlled, 
double-blind 
trial. 
Fifty patients 
undergoing 
colonoscopy 
were 
randomized to 
either 
midazolam 
and fentanyl 
group or 
propofol and 
remifentanil 
group 
administered 
by patient-
controlled 
sedation. 
Induction of 
sedation and 
recovery was 
significantly 
shorter in the 
propofol and 
remifentanil 
group than in 
the midazolam 
and fentanyl 
group. 
Fixed ratios of 
narcotics and 
sedatives were 
used in this 
study, which 
allowed single 
syringe use.  
However, this 
does not allow 
for tailoring 
drug doses to 
patients. 
The authors state that 
when applied to 
other procedures, the 
efficacy of this form 
of sedation is not 
known.  However, 
forming an efficient 
sedation protocol 
could increase 
throughput of 
patients and decrease 
costs. 
  
  
3
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
McQuaid, K. R., and 
Laine, L. (2008). “A 
systematic review and 
meta-analysis of 
randomized, 
controlled trials of 
moderate sedation for 
routine endoscopic 
procedures.” 
Level 1-/ 
Grade A 
Systematic 
review of 
randomized 
controlled trials 
36 studies, all 
randomized 
controlled 
trials, were 
reviewed in 
this study.  
Databases 
EMBASE 
(1980- 
January 2007) 
and 
MEDLINE 
(1950 to 
January 2007) 
were searched 
for the RCTs. 
36 studies were 
included in this 
systematic review, 
and many forms 
of sedation were 
reviewed.  
Sedation and 
recovery times 
were shorter with 
propofol sedation 
versus sedation 
with narcotics, 
benzodiazepines, 
combination of 
narcotics and 
benzodiazepines, 
or combination of 
narcotics and 
propofol. 
Design, 
regimen, and 
outcome 
variability and 
poor 
methodologic 
quality (Jadad 
score <3 in 
23/36 trials. 
Controlled trials 
recommended to 
study lower doses of 
propofol plus 
narcotics and 
benzodiazepines 
versus propofol 
alone or 
benzodiazepines and 
narcotics. 
 
 
  
  
3
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Obara, K., Haruma, K., 
Irisawa, A., Kaise, M., 
Gotoda, T., Sugiyama, 
M., Tanabe, S., 
Horiuchi, A., Fujita, 
N., Ozaki, M., 
Yoshida, M., Matsui, 
T., Ichinose, M., and 
Kaminishi, M. (2015). 
“Guidelines for 
sedation in 
gastroenterological 
endoscopy.” 
Level 4/ 
Grade D 
Guideline/ 
Expert opinion/ 
Commentary 
N/A Initial 
guidelines for 
endoscopy 
sedation were 
created in Japan 
in 1999, updated 
in 2006, and 
updated again in 
2010.  They 
review the 
pharmacology 
of different 
drugs used for 
sedation for 
endoscopic 
procedures.   
Several authors 
of this study 
received 
royalty, lecture 
fees, 
scholarships, 
and study 
group 
sponsorships 
from various 
pharmaceutical 
companies; 
however, no 
funding was 
received for 
this study. 
The authors agree 
that change occurs 
rapidly in the 
medical field, so 
guidelines should be 
reviewed and 
changed accordingly 
every few years. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Poulos, J. E., 
Kalogerinis, P. T., and 
Caudle, J. N. (2013). 
“Propofol compared 
with combination 
propofol or 
midazolam/fentanyl for 
endoscopy in a 
community setting.” 
Level 2+/ 
Grade C 
Retrospective 
Cohort Study 
Data from 951 
patients at an 
outpatient 
endoscopy 
center from 
2007 to 2010 
were studied.  
Those patients 
were 
undergoing 
colonoscopy 
or EGD at the 
time. 
Propofol 
sedation 
generated less 
time in the 
endoscopy unit, 
faster recovery, 
and faster 
discharge than 
did propofol, 
midazolam, and 
fentanyl, or 
midazolam and 
fentanyl. 
Non-
randomized, 
non-blinded 
study that 
utilized a 
retrospective 
chart review 
This study 
recommends that 
various states follow 
their board of 
nursing regulations 
in administration of 
propofol before 
making any practice 
changes.  Many 
BONs do not allow 
propofol to be 
administered by 
anyone not trained in 
rescue from deep 
sedation. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Sipe, B. W., Rex, D. 
K., Latinovich, D., 
Overley, C., Kinser, K., 
Bratcher, L., and 
Kareke, D.  (2002). 
“Propofol versus 
midazolam/meperidine 
for outpatient 
colonoscopy: 
administration by 
nurses supervised by 
endoscopists.” 
Level 
1+/Grade A 
Randomized, 
blinded trial 
80 ASA class 
I or II 
outpatients 
undergoing 
colonoscopy 
were 
randomized to 
receive either 
propofol or 
midazolam 
and 
meperidine for 
sedation.  All 
drugs were 
administered 
by nurses and 
supervised by 
the 
endoscopist 
Patients sedated 
with propofol 
for 
colonoscopies 
had faster 
sedation times, 
deeper sedation, 
quicker 
recoveries, and 
were discharged 
sooner than 
patients sedated 
with midazolam 
and meperidine.  
4 patients in the 
midazolam and 
meperidine 
group 
developed 
minor 
complications 
(hypotension, 
bradycardia, 
tachycardia) and 
1 patient in the 
propofol group 
desaturated 
during an 
episode of 
epistaxis. 
Single center 
study. 
Sedation, 
including 
propofol, 
performed by 
registered 
nurses 
supervised by 
endoscopists.  
Propofol 
typically 
administered 
by anesthesia 
providers. 
Only ASA I 
or II patients 
included. 
This study 
recommends that 
propofol be used 
for sedation for 
colonoscopies 
because patients 
typically 
experience less 
pain than with 
other sedation 
methods. 
  
4
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Vargo, J. J., Zuccaro 
Jr., G., Dumot, J. A., 
Shermock, K. M., 
Morrow, J. B., 
Conwell, D. L., Trolli, 
P. A., and Maurer, W. 
G. (2002). 
“Gastroenterologists-
administered propofol 
versus meperidine and 
midazolam for 
advanced upper 
endoscopy: A 
prospective, 
randomized trial.” 
Level 1+/ 
Grade A 
Prospective, 
single-blind, 
randomized 
controlled trial. 
75 patients 
presenting for 
ERCP and 
EUS were 
randomly 
selected for 
sedation by 
propofol or 
midazolam 
and 
meperidine.  
All patients 
were similar in 
age, sex, BMI, 
ASA physical 
status, 
education, and 
sedation 
history. 
Patients in the 
propofol 
sedation group 
had shorter 
recovery times 
and were 
quicker to 
recover to 
baseline activity 
and dietary level 
24 hours post-
procedure.  
However, the 
cost to 
administer 
propofol was 
higher than the 
administration 
of meperidine 
and midazolam.  
Patients 
included in this 
study were 
ASA I or II 
and generally 
healthy.  
Patients ASA 
III or higher 
have more 
comorbidities 
and respond to 
medications 
differently.  
Also, in this 
study, propofol 
was 
administered 
by bolus 
injections 
instead of 
infusion which 
may cause 
variability in 
the plasma 
levels of the 
drug and 
sedation. 
The authors of this 
study recommend 
further studies of 
nurse-administered 
propofol to 
decrease the cost of 
propofol sedation 
for patients.  
However, the 
policies of propofol 
administration 
must be reviewed 
carefully. 
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Author/Year/Title Level/Grade Design Sample/Data 
Collection 
Findings Limitations Recommendations 
Watkins, T. J., Bonds, 
R. L., Hodges, K., 
Goettle, B. B., Dobson, 
D. A. M., and Maye, J. 
P. (2014). “Evaluation 
of postprocedure 
cognitive function 
using 3 distinct 
standard sedation 
regimens for 
endoscopic 
procedures.” 
Level 
1+/Grade A 
Prospective, 
single-blind, 
randomized trial 
96 patients, 
both male, and 
female were 
included in 
this study.  
The sample 
was a 
convenience 
sample of 
patients 
presenting for 
colonoscopy 
at a medical 
center in 
Maryland. 
This authors of 
this study 
concluded that 
propofol 
sedation has the 
least impact on 
postoperative 
cognitive 
dysfunction at 
both 24 and 48 
hours post-
procedure than 
the other 
methods of 
sedation 
studied, 
propofol plus 
fentanyl or 
midazolam plus 
fentanyl. 
Only ASA I 
and II patients 
included, 
patients, were 
presented with 
questionnaires 
both before and 
after their 
procedure 
which could 
have 
familiarized 
them with the 
questions and 
answers, and 
the need to 
follow up with 
patients at both 
24 and 48 
hours post-
procedure. 
The authors of this 
study recommend 
that propofol alone 
may be optimal for 
endoscopy 
procedures when 
attempting to 
decrease POCD 
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APPENDIX C – Logic Model 
Input Activities Output Outcome-Short Outcome-
Intermediate 
Outcome-Long 
Term 
IT assistance to 
access 
colonoscopy charts 
in GI endoscopy 
suite from 2015  
 
IRB approval 
 
Cost information 
of medications 
used for sedation 
 
Cost information 
regarding 
anesthesia provider 
administration of 
sedation 
 
Adherence to 
HIPAA guidelines 
 
 
Literature review 
to determine 
sedation practices 
in GI endoscopy 
suite 
 
Statistical analysis 
of different 
sedation methods 
to determine of 
significance is 
present 
 
Presentation to 
gastroenterologists 
regarding cost-
savings potential 
by administration 
of propofol for 
sedation 
 
 
Results of 
statistical analysis 
of difference in 
sedation methods 
 
Cost savings 
regarding 
medication 
administration  
 
Cost of anesthesia 
provider 
administration of 
sedation versus 
RN administration 
Discharge times 
from PACU after 
colonoscopy 
decreased 
 
Adaptation of new 
flow in GI 
endoscopy suite 
 
Change in attitudes 
of GI staff about 
sedation practices 
Use of propofol 
exclusively for 
sedation for 
colonoscopies in 
GI endoscopy suite 
 
Costs reduced for 
GI department 
 
Costs reduced for 
patients 
undergoing 
colonoscopy 
 
 
Sedation practice 
change 
implemented 
 
Propofol 
implemented for 
sedation for EGDs 
in the GI 
endoscopy suite 
 
Budget improved 
for GI department 
due to savings 
from colonoscopy 
sedation 
 
Patient satisfaction 
improved 
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APPENDIX D – SWOT Analysis 
Strengths Weaknesses 
• No cost for the facility where 
project will be conducted 
• Retrospective chart review 
• Only patients ASA I or II included 
• Unable to control variables 
• Documentation errors may be 
present 
Opportunities Threats 
• Increase revenue for the facility 
• Decrease costs for the patient 
• Increase patient satisfaction 
• Improve patient safety 
• Engage providers in EBP 
• Disinterest by gastroenterologists 
performing colonoscopies 
• Disinterest by administration of the 
organization 
• Cost for administration of propofol 
by anesthesia providers outweighs 
savings from decreased time until 
discharge from PACU 
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APPENDIX E – ASA PS Classification  
Table A2.  
ASA Physical Status Classification 
 
ASA PS Classification Description 
ASA I A normal healthy patient. 
ASA II A patient with mild systemic disease. 
ASA III A patient with severe systemic disease. 
ASA IV A patient with severe systemic disease that 
is a constant threat to life. 
ASA V A moribund patient who is not expected to 
survive without the operation. 
ASA VI A declared brain-dead patient whose 
organs are being removed for donor 
purposes. 
E Emergency surgery 
(American Society of Anesthesiologists, 2014) 
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APPENDIX F – Data Collection Tool 
 
 
APPENDIX F- DATA COLLECTION TOOL 
 
Identification # _______________  
 
Procedure Date _______________ Age _______________ Sex ______________ 
 
ASA classification _____________ 
 
PMH:  
 
 
 
 
Home Medications: 
 
 
 
 
Allergies:  
 
 
 
 
Type of Sedation: Moderate Sedation or MAC 
 
 
 
 
Sedation start time Sedation end time Total time 
(minutes) 
 
 
  
 
Procedure start time Procedure end time Total time (minutes) 
 
 
  
 
PACU start time PACU discharge time Total time (minutes) 
   
 
 
Procedure end time PACU discharge time Total time (minutes) 
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APPENDIX G – Data Collection Tool- Cost Analysis 
Cost for sedation procedure: moderate 
sedation 
 
 
Cost for sedation procedure: MAC by 
anesthesia providers 
 
 
Cost of 50ml vial of propofol: 
 
 
Cost of 2ml vial of midazolam: 
 
 
Cost of 2ml vial of fentanyl: 
 
 
Cost of 50mg vial of meperidine: 
 
 
Cost of other medication (please specify): 
 
 
Cost of other medication (please specify): 
 
 
Reimbursement for colonoscopies:  
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APPENDIX H – IRB Approval 
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APPENDIX I – Letter of Support 
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